Michele Fabrazzo

Dr. Michele Fabrazzo

Department of Psychiatry, University of Campania Luigi Vanvitelli

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2010 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
FCFrancesco Catapano
Francesco Catapano
FPFrancesco Perris
Francesco Perris
MFMichele Fabrazzo
Michele Fabrazzo
VCValeria Cioffi
Valeria Cioffi
DGDomenico Giacco
Domenico Giacco
MMMario Maj
Mario Maj

20 May 1997 in Psychiatry Research
Verified
Journal Article
Closed access
PMPalmiero Monteleone
Palmiero Monteleone
MFMichele Fabrazzo
Michele Fabrazzo
ATAlfonso Tortorella
Alfonso Tortorella
MMMario Maj
Mario Maj

13 September 2004 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
PMPalmiero Monteleone
Palmiero Monteleone
MFMichele Fabrazzo
Michele Fabrazzo
VMVassilis Martiadis
Vassilis Martiadis
CSCristina Serritella
Cristina Serritella
MPMarilena Pannuto
Marilena Pannuto
MMMario Maj
Mario Maj
Background. Several lines of evidence indicate a role of the brain-derived neurotrophic factor (BDNF) in the modulation of eating behaviour. Therefore, alterations in the physiology of this neurotrophin may be involved in the pathogenesis of eating disorders. In the present study, we investigated serum levels of BDNF in patients with anorexia nervosa (AN), bulimia nervosa (BN) and binge-eating disorder (BED).Method. Ninety-nine drug-free women (27 with AN, 24 with BN, 24 with BED and 24 healthy controls) underwent both a blood sample collection in the morning and diagnostic and psychopathological assessments by means of structured clinical interviews and ad-hoc rating scales. Serum levels of BDNF, 17β-oestradiol, FT3 and FT4 were measured.Results. Compared to healthy controls, serum levels of BDNF were significantly reduced in underweight AN women and in normal weight BN women, but not in overweight BED women. Changes in circulating BDNF levels were not affected by the presence of co-morbid depressive disorders. No significant correlation emerged between neurotrophin concentrations and psychopathological, nutritional, demographic and hormonal variables.Conclusions. These findings evidentiate alterations in serum BDNF levels in malnourished patients with AN or BN, but not in well-nourished individuals with BED. Since BDNF seems to exert a satiety effect, its reduction may represent an adaptive change to counteract the decreased calorie ingestion of AN and BN individuals.

1 April 2005 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
PMPalmiero Monteleone
Palmiero Monteleone
MFMichele Fabrazzo
Michele Fabrazzo
ATAlfonso Tortorella
Alfonso Tortorella
VMVassilis Martiadis
Vassilis Martiadis
CSCristina Serritella
Cristina Serritella
MMMario Maj
Mario Maj

1 April 2005 in Biological Psychiatry
Verified
Journal Article
Closed access
PMPalmiero Monteleone
Palmiero Monteleone
VMVassilis Martiadis
Vassilis Martiadis
ARAntonello Emilio Rigamonti
Antonello Emilio Rigamonti
MFMichele Fabrazzo
Michele Fabrazzo
CGClaudio Giordani
Claudio Giordani
MMMario Maj
Mario Maj

25 November 2021 in European Psychiatry
Verified
Journal Article
Open access
PDF file
MFMichele Fabrazzo
Michele Fabrazzo
SCSalvatore Cipolla
Salvatore Cipolla
SSSimona Signoriello
Simona Signoriello
ACAlessio Camerlengo
Alessio Camerlengo
GCGiulia Calabrese
Giulia Calabrese
SGSilvana Galderisi
Silvana Galderisi
Background: Mental disorders in comorbidity with chronic skin diseases may worsen disease outcome and patients’ quality of life. We hypothesized the comorbidity of depression, anxiety syndromes, or symptoms as attributable to biological mechanisms that the combined diseases share.Methods: We conducted a systematic review based on the Preferred Reporting Items for Systematic Review and Meta-Analysis statement searching into PubMed, PsycInfo, and Scopus databases. We examined the literature regarding the comorbidity of psoriasis (Ps), atopic dermatitis (AD), or hidradenitis suppurativa with depression and/or anxiety in adults ≥18 years and the hypothetical shared underlying biological mechanisms.Results: Sixteen studies were analyzed, mostly regarding Ps and AD. Brain-derived neurotrophic factor/tropomyosin receptor kinase B signaling and nuclear factor kappa-light-chain-enhancer of activated B cells/p38 mitogen-activated protein kinase pathways arose as shared mechanisms in Ps animal models with depression- and/or anxiety-like behaviors. Activated microglia and neuroinflammatory responses emerged in AD depressive models. As to genetic studies, atopic-dermatitis patients with comorbid anxiety traits carried the short variant of serotonin transporter and a polymorphism of the human translocator protein gene. A GA genotype of catechol-O-methyltransferase gene was instead associated with Ps. Reduced natural killer cell activity, IL-4, serotonin serum levels, and increased plasma cortisol and IgE levels were hypothesized in comorbid depressive AD patients. In Ps patients with comorbid depression, high serum concentrations of IL-6 and IL-18, as well as IL-17A, were presumed to act as shared inflammatory mechanisms.Conclusions: Further studies should investigate mental disorders and chronic skin diseases concurrently across patients’ life course and identify their temporal relation and biological correlates. Future research should also identify biological characteristics of individuals at high risk of the comorbid disorders and associated complications.